So the manufacturer of the Zileuton ??? which by statutory requirement receives all adverse drug incidence reports from doctors ??? cannot, for fear of illegal ???promotion,??? truthfully inform the public about the risks and benefits of Zileuton in treating CML. And didn???t somebody state recently that, ???manufacturers have superior access to information about their drugs, especially in the pos